Conferences Geron is attending in 2026–2027
Geron is listed at 2 conferences on Tnuki's calendar in 2026–2027: ASH 2026 (exhibiting) and ASCO 2027 (exhibiting). Geron develops imetelstat, a telomerase inhibitor for treating myelofibrosis and lower-risk myelodysplastic syndromes. As of Oct 17, 2026.
| Conference | Details | Involvement | Tnuki guide |
|---|---|---|---|
ASH 2026 Annual Meeting & ExpositionHematologists & blood cancer researchersOfficial site |
New Orleans, LA ~30k attendees | ExhibitorAs published by American Society of Hematology Booth 1929Program 3 symposia
Attendee mix: Mostly clinical; hematologists, KOLs, hematologic-oncology researchers, medical affairs and cell-therapy biopharma teams
|
Open the guide Search and filter attendees |
ASCO Annual Meeting 2027World’s largest clinical oncology meetingOfficial site |
Chicago, IL ~44k attendees | ExhibitorAs published by American Society of Clinical Oncology Booth 14149
Attendee mix: Mostly clinical; oncologists, KOLs, clinical researchers, medical affairs and oncology biopharma teams
|
Open the guide Search and filter attendees |
We hold published exhibitor, sponsor, program or attendee lists for 54 of the 156 conferences on our calendar, so this page shows Geron’s involvement at those 54 only — it is not a complete record of where they go. Organizers typically publish a list around six months before the event, so coverage grows over time.
Instantly find decision makers at Geron
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!